Showing all 7 results
Invasive and noninvasive procedures are a common and necessary component in the management of infants, children, and adolescents with acute and chronic diseases. As technology continues to expand, there are an increasing number of techniques that require sedation outside of the operating room.Authored by experts in a variety of specialties, Procedural Sedation for Infants, Children, and Adolescents is a comprehensive guide for the initial design and implementation of a procedural sedation program and a tool to educate pediatric health care professionals on medications used for sedation, associated adverse events, and treatment of these adverse events.C
This atlas is a practical guide for practitioners who perform interventional procedures with radiographic guidance to alleviate acute or chronic pain. The author provides an overview of each technique, with detailed full-color illustrations of the relevant anatomy, technical aspects of each treatment, and a description of potential complications. For this revised and expanded Second Edition, the author also discusses indications for each technique, as well as medical evidence on the technique’s applicability.
Designed for quick point-of-care reference, this handbook offers evidence-based guidelines on use of antiepileptic drugs for seizures, psychiatric disorders, pain, and headache. Chapters cover all drugs, including the recently approved drug pregabalin. For each drug, the authors list FDA-approved indications and summarize the evidence for efficacy and tolerability from clinical trials for epileptic, psychiatric, pain, and headache indications. Also included are recommendations from professional societies such as the American Academy of Neurology, American Psychiatric Association, and Association for the Study of Headache.
In Your Brain on Food, Dr. Gary Wenk expands his discussion of the effects of specific foods on the brain in a completely updated second edition. From investigations into the benefits and risks of supplements, to the action of gluten in the brain and marijuana’s potential for pain relief, Dr. Wenk draws on the latest science to answer a range of fascinating questions such as:-Is your aluminum cookware hurting you?-Can tryptophan supplements improve your mood?-How do fruits and vegetables protect us from aging?-Why does eating chocolate make you feel so angry?-Does our brain want us to be obese?Never forget–everything we consume can affect how we think, feel, and act.N
Do antidepressants work, or are they glorified dummy pills? How can we tell?
In “Ordinarily Well,” the celebrated psychiatrist and author Peter D. Kramer examines the growing controversy about the popular medications. A practicing doctor who trained as a psychotherapist and worked with pioneers in psychopharmacology, Kramer combines moving accounts of his patients dilemmas with an eye-opening history of drug research to cast antidepressants in a new light.
Kramer homes in on the moment of clinical decision making: Prescribe or not? What evidence should doctors bring to bear? Using the wide range of reference that readers have come to expect in his books, he traces and critiques the growth of skepticism toward antidepressants.
Chronic pain affects every facet of a patient’s life, and nowhere is this more evident than in the complex arena of family life. Chronic Pain and Family: a Clinical Perspective examines typical family issues associated with prolonged illness, offering realistic ways to approach them in therapy.
This book presents a contemporary review of the field of pain therapeutics, including the historical medicines which still dominate standard of care treatments, as well as the new mechanisms and combinations/reformulations that have dominated the regulatory approvals over the last decade. In addition, it provides a deep review of the key biological mechanisms currently under investigation for their utility into the treatment of pain, such as ion channels, opiates and others.Additional discussion highlights the current challenges of pain research, covering a range of topics from difficulties in identifying new targets and pre-clinical models to the current regulatory and commercial challenges.
Showing all 7 results